Literature DB >> 31227554

K2 Capsule Depolymerase Is Highly Stable, Is Refractory to Resistance, and Protects Larvae and Mice from Acinetobacter baumannii Sepsis.

Hugo Oliveira1, Ana Mendes2,3, Alexandra G Fraga2,3, Alice Ferreira1, Andreia I Pimenta4, Dalila Mil-Homens4, Arsénio M Fialho4, Jorge Pedrosa2,3, Joana Azeredo5.   

Abstract

Acinetobacter baumannii is emerging as a major nosocomial pathogen in intensive care units. The bacterial capsules are considered major virulence factors, and the particular A. baumannii capsular type K2 has been associated with high antibiotic resistance. In this study, we identified a K2 capsule-specific depolymerase in a bacteriophage tail spike C terminus, a fragment that was heterologously expressed, and its antivirulence properties were assessed by in vivo experiments. The K2 depolymerase is active under a broad range of environmental conditions and is highly thermostable, with a melting point (Tm ) at 67°C. In the caterpillar larva model, the K2 depolymerase protects larvae from bacterial infections, using either pretreatments or with single-enzyme injection after bacterial challenge, in a dose-dependent manner. In a mouse sepsis model, a single K2 depolymerase intraperitoneal injection of 50 μg is able to protect 60% of mice from an otherwise deadly infection, with a significant reduction in the proinflammatory cytokine profile. We showed that the enzyme makes bacterial cells fully susceptible to the host complement system killing effect. Moreover, the K2 depolymerase is highly refractory to resistance development, which makes these bacteriophage-derived capsular depolymerases useful antivirulence agents against multidrug-resistant A. baumannii infections.IMPORTANCE Acinetobacter baumannii is an important nosocomial pathogen resistant to many, and sometimes all, antibiotics. The A. baumannii K2 capsular type has been associated with elevated antibiotic resistance. The capsular depolymerase characterized here fits the new trend of alternative antibacterial agents needed against multidrug-resistant pathogens. They are highly specific, stable, and refractory to resistance, as they do not kill bacteria per se; instead, they remove bacterial surface polysaccharides, which diminish the bacterial virulence and expose them to the host immune system.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  A. baumanniizzm321990; antivirulence; bacteriophage; capsular depolymerase

Mesh:

Substances:

Year:  2019        PMID: 31227554      PMCID: PMC6696962          DOI: 10.1128/AEM.00934-19

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  37 in total

1.  The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Authors:  Thomas A Russo; Nicole R Luke; Janet M Beanan; Ruth Olson; Shauna L Sauberan; Ulrike MacDonald; L Wayne Schultz; Timothy C Umland; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 2.  Capsular polysaccharides and their role in virulence.

Authors:  Clare M Taylor; Ian S Roberts
Journal:  Contrib Microbiol       Date:  2005

3.  Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.

Authors:  John S Esterly; Milena Griffith; Chao Qi; Michael Malczynski; Michael J Postelnick; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

4.  Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase.

Authors:  Naseem Mushtaq; Maria B Redpath; J Paul Luzio; Peter W Taylor
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

5.  Genome-wide analysis of DNA repeats in Burkholderia cenocepacia J2315 identifies a novel adhesin-like gene unique to epidemic-associated strains of the ET-12 lineage.

Authors:  Dalila Mil-Homens; Eduardo P C Rocha; Arsenio M Fialho
Journal:  Microbiology       Date:  2009-12-17       Impact factor: 2.777

6.  Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.

Authors:  Dawn M Sievert; Philip Ricks; Jonathan R Edwards; Amy Schneider; Jean Patel; Arjun Srinivasan; Alex Kallen; Brandi Limbago; Scott Fridkin
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-27       Impact factor: 3.254

Review 7.  Capsules of Escherichia coli, expression and biological significance.

Authors:  K Jann; B Jann
Journal:  Can J Microbiol       Date:  1992-07       Impact factor: 2.419

8.  Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.

Authors:  Anton Y Peleg; Sebastian Jara; Divya Monga; George M Eliopoulos; Robert C Moellering; Eleftherios Mylonakis
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

9.  A common pathway for O-linked protein-glycosylation and synthesis of capsule in Acinetobacter baumannii.

Authors:  Robert G Lees-Miller; Jeremy A Iwashkiw; Nichollas E Scott; Andrea Seper; Evgeny Vinogradov; Stefan Schild; Mario F Feldman
Journal:  Mol Microbiol       Date:  2013-07-12       Impact factor: 3.501

10.  A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications.

Authors:  Chi-Tai Fang; Yi-Ping Chuang; Chia-Tung Shun; Shan-Chwen Chang; Jin-Town Wang
Journal:  J Exp Med       Date:  2004-03-01       Impact factor: 14.307

View more
  15 in total

1.  A Tailspike with Exopolysaccharide Depolymerase Activity from a New Providencia stuartii Phage Makes Multidrug-Resistant Bacteria Susceptible to Serum-Mediated Killing.

Authors:  Hugo Oliveira; Graça Pinto; Bruna Mendes; Oscar Dias; Hanne Hendrix; Ergun Akturk; Jean-Paul Noben; Jan Gawor; Małgorzata Łobocka; Rob Lavigne; Joana Azeredo
Journal:  Appl Environ Microbiol       Date:  2020-06-17       Impact factor: 4.792

Review 2.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

Review 3.  Biological foundations of successful bacteriophage therapy.

Authors:  Carola Venturini; Aleksandra Petrovic Fabijan; Alicia Fajardo Lubian; Stefanie Barbirz; Jonathan Iredell
Journal:  EMBO Mol Med       Date:  2022-05-27       Impact factor: 14.260

4.  Characterization and Functional Studies of a Novel Depolymerase Against K19-Type Klebsiella pneumoniae.

Authors:  Yunfen Hua; Yongqin Wu; Minjie Guo; Ruijing Ma; Qingchuan Li; Zheyuan Hu; Hongrui Chen; Xingyu Zhang; Hui Li; Qingtian Li; Ping He
Journal:  Front Microbiol       Date:  2022-06-22       Impact factor: 6.064

5.  Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host.

Authors:  L Blasco; I Bleriot; M González de Aledo; L Fernández-García; O Pacios; H Oliveira; M López; C Ortiz-Cartagena; F Fernández-Cuenca; Á Pascual; L Martínez-Martínez; J Pachón; J Azeredo; M Tomás
Journal:  Antimicrob Agents Chemother       Date:  2022-01-18       Impact factor: 5.938

6.  Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model.

Authors:  ArunKumar GaneshPrasad; Saisubramanian Nagarajan; Niranjana Sri Sundaramoorthy; Subramaniam Thothathri; Muthumeenakshi Bhaskaran
Journal:  AMB Express       Date:  2021-02-15       Impact factor: 3.298

7.  Isolation, characterization and application of bacteriophage PSDA-2 against Salmonella Typhimurium in chilled mutton.

Authors:  Ziyu Sun; Hui Wen; Li Ma; Zhongjun Chen
Journal:  PLoS One       Date:  2022-01-24       Impact factor: 3.240

8.  Association of capsular polysaccharide locus 2 with prognosis of Acinetobacter baumannii bacteraemia.

Authors:  Jia-Ling Yang; Chia-Jui Yang; Yu-Chung Chuang; Wang-Huei Sheng; Yee-Chun Chen; Shan-Chwen Chang
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

9.  Phage φAB6-Borne Depolymerase Combats Acinetobacter baumannii Biofilm Formation and Infection.

Authors:  Md Shahed-Al-Mahmud; Rakesh Roy; Febri Gunawan Sugiokto; Md Nazmul Islam; Ming-Der Lin; Ling-Chun Lin; Nien-Tsung Lin
Journal:  Antibiotics (Basel)       Date:  2021-03-09

Review 10.  Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application.

Authors:  Katarzyna M Danis-Wlodarczyk; Daniel J Wozniak; Stephen T Abedon
Journal:  Antibiotics (Basel)       Date:  2021-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.